Annual Total Liabilities
$125.26 M
-$412.26 M-76.70%
December 31, 2023
Summary
- As of February 12, 2025, SMMT annual total liabilities is $125.26 million, with the most recent change of -$412.26 million (-76.70%) on December 31, 2023.
- During the last 3 years, SMMT annual total liabilities has risen by +$102.21 million (+443.53%).
- SMMT annual total liabilities is now -76.70% below its all-time high of $537.51 million, reached on December 31, 2022.
Performance
SMMT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$64.93 M
-$81.85 M-55.76%
September 30, 2024
Summary
- As of February 12, 2025, SMMT quarterly total liabilities is $64.93 million, with the most recent change of -$81.85 million (-55.76%) on September 30, 2024.
- Over the past year, SMMT quarterly total liabilities has dropped by -$81.85 million (-55.76%).
- SMMT quarterly total liabilities is now -87.92% below its all-time high of $537.51 million, reached on December 31, 2022.
Performance
SMMT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SMMT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.7% | -55.8% |
| 3 y3 years | +443.5% | -87.9% |
| 5 y5 years | +427.7% | +303.1% |
SMMT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -76.7% | +316.3% | -87.9% | +194.1% |
| 5 y | 5-year | -76.7% | +620.5% | -87.9% | +303.1% |
| alltime | all time | -76.7% | >+9999.0% | -87.9% | >+9999.0% |
Summit Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $64.93 M(-55.8%) |
| Jun 2024 | - | $146.78 M(+10.7%) |
| Mar 2024 | - | $132.57 M(+5.8%) |
| Dec 2023 | $125.26 M(-76.7%) | $125.26 M(+5.2%) |
| Sep 2023 | - | $119.10 M(+1.1%) |
| Jun 2023 | - | $117.77 M(-3.0%) |
| Mar 2023 | - | $121.42 M(-77.4%) |
| Dec 2022 | $537.51 M(+1686.4%) | $537.51 M(+2334.5%) |
| Sep 2022 | - | $22.08 M(-50.3%) |
| Jun 2022 | - | $44.40 M(-14.7%) |
| Mar 2022 | - | $52.06 M(+73.0%) |
| Dec 2021 | $30.09 M(+30.6%) | $30.09 M(+14.1%) |
| Sep 2021 | - | $26.38 M(+1.1%) |
| Jun 2021 | - | $26.09 M(-65.8%) |
| Mar 2021 | - | $76.39 M(+231.5%) |
| Dec 2020 | $23.05 M(+32.6%) | - |
| Dec 2020 | - | $23.05 M(+15.2%) |
| Sep 2020 | - | $20.00 M(-6.3%) |
| Mar 2020 | - | $21.35 M(+32.5%) |
| Dec 2019 | $17.39 M(-26.8%) | - |
| Oct 2019 | - | $16.11 M(-10.0%) |
| Jul 2019 | - | $17.90 M(-7.8%) |
| Apr 2019 | - | $19.41 M(-18.2%) |
| Jan 2019 | $23.74 M(-71.2%) | - |
| Jan 2019 | - | $23.74 M(+11.2%) |
| Oct 2018 | - | $21.34 M(+18.4%) |
| Jul 2018 | - | $18.02 M(-77.4%) |
| Apr 2018 | - | $79.81 M(-3.3%) |
| Jan 2018 | $82.56 M(+60.8%) | - |
| Jan 2018 | - | $82.56 M(+91.9%) |
| Oct 2017 | - | $43.03 M(-13.1%) |
| Jul 2017 | - | $49.50 M(-1.6%) |
| Apr 2017 | - | $50.28 M(-2.1%) |
| Jan 2017 | $51.35 M(+301.6%) | - |
| Jan 2017 | - | $51.35 M(+0.4%) |
| Oct 2016 | - | $51.12 M(+852.7%) |
| Jul 2016 | - | $5.37 M(-5.2%) |
| Apr 2016 | - | $5.66 M |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2016 | $12.79 M(+31.9%) | - |
| Jan 2016 | - | $12.79 M(+134.8%) |
| Oct 2015 | - | $5.44 M(+3.1%) |
| Jul 2015 | - | $5.28 M(+0.1%) |
| Apr 2015 | - | $5.28 M(-45.6%) |
| Jan 2015 | $9.69 M(+132.0%) | - |
| Jan 2015 | - | $9.69 M(+65.7%) |
| Oct 2014 | - | $5.85 M(+1.8%) |
| Jul 2014 | - | $5.75 M(+37.5%) |
| Jan 2014 | $4.18 M(+73.3%) | - |
| Jan 2014 | - | $4.18 M(+87.8%) |
| Jul 2013 | - | $2.22 M(-7.7%) |
| Jan 2013 | $2.41 M(+3.0%) | - |
| Jan 2013 | - | $2.41 M(+124.0%) |
| Jul 2012 | - | $1.08 M(-54.0%) |
| Jan 2012 | $2.34 M(+4.6%) | - |
| Jan 2012 | - | $2.34 M(-31.5%) |
| Jul 2011 | - | $3.42 M(+52.7%) |
| Jan 2011 | $2.24 M(-56.6%) | - |
| Jan 2011 | - | $2.24 M(-51.2%) |
| Jul 2010 | - | $4.59 M(-11.0%) |
| Jan 2010 | $5.15 M(-33.6%) | - |
| Jan 2010 | - | $5.15 M(-3.1%) |
| Jul 2009 | - | $5.32 M(-31.5%) |
| Jan 2009 | $7.77 M(-49.2%) | - |
| Jan 2009 | - | $7.77 M(-48.9%) |
| Jul 2008 | - | $15.20 M(-0.7%) |
| Jan 2008 | $15.30 M(+141.8%) | - |
| Jan 2008 | - | $15.30 M(+10.3%) |
| Jul 2007 | - | $13.88 M(+119.3%) |
| Jan 2007 | $6.33 M(+153.9%) | - |
| Jan 2007 | - | $6.33 M(+257.3%) |
| Jul 2006 | - | $1.77 M(-28.9%) |
| Jan 2006 | $2.49 M(+611.6%) | - |
| Jan 2006 | - | $2.49 M(+155.5%) |
| Jul 2005 | - | $975.40 K(+178.5%) |
| Jan 2005 | $350.20 K | - |
| Jan 2005 | - | $350.20 K(+64.3%) |
| Jul 2004 | - | $213.20 K |
FAQ
- What is Summit Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Summit Therapeutics?
- What is Summit Therapeutics annual total liabilities year-on-year change?
- What is Summit Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Summit Therapeutics?
- What is Summit Therapeutics quarterly total liabilities year-on-year change?
What is Summit Therapeutics annual total liabilities?
The current annual total liabilities of SMMT is $125.26 M
What is the all time high annual total liabilities for Summit Therapeutics?
Summit Therapeutics all-time high annual total liabilities is $537.51 M
What is Summit Therapeutics annual total liabilities year-on-year change?
Over the past year, SMMT annual total liabilities has changed by -$412.26 M (-76.70%)
What is Summit Therapeutics quarterly total liabilities?
The current quarterly total liabilities of SMMT is $64.93 M
What is the all time high quarterly total liabilities for Summit Therapeutics?
Summit Therapeutics all-time high quarterly total liabilities is $537.51 M
What is Summit Therapeutics quarterly total liabilities year-on-year change?
Over the past year, SMMT quarterly total liabilities has changed by -$81.85 M (-55.76%)